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Abstract
Background: Inflammation of the middle ear (otitis media) is very common and can lead to serious complications
if not resolved. Genetic studies suggest an inherited component, but few of the genes that contribute to this
condition are known. Mouse mutants have contributed significantly to the identification of genes predisposing to
otitis media
Results: The dearisch mouse mutant is an ENU-induced mutant detected by its impaired Preyer reflex (ear flick in
response to sound). Auditory brainstem responses revealed raised thresholds from as early as three weeks old.
Pedigree analysis suggested a dominant but partially penetrant mode of inheritance. The middle ear of dearisch
mutants shows a thickened mucosa and cellular effusion suggesting chronic otitis media with effusion with
superimposed acute infection. The inner ear, including the sensory hair cells, appears normal. Due to the low
penetrance of the phenotype, normal backcross mapping of the mutation was not possible. Exome sequencing
was therefore employed to identify a non-conservative tyrosine to cysteine (Y71C) missense mutation in the Islet1
gene, Isl1
Drsh. Isl1 is expressed in the normal middle ear mucosa. The findings suggest the Isl1
Drshmutation is likely
to predispose carriers to otitis media.
Conclusions: Dearisch, Isl1
Drsh, represents the first point mutation in the mouse Isl1 gene and suggests a previously
unrecognized role for this gene. It is also the first recorded exome sequencing of the C3HeB/FeJ background
relevant to many ENU-induced mutants. Most importantly, the power of exome resequencing to identify ENU-
induced mutations without a mapped gene locus is illustrated.
Background
Inflammation of the middle ear mucosa associated with
fluid accumulation is known as otitis media [1]. It is
very common, being the most frequent cause of surgery
in children in the developed world. A recent European
cohort reports 35% of children had at least one episode
of otitis media before the age of 2 years [2], while a
North American cohort found 91% of children did [3],
and a range of 50 to 85% of 3 year olds with one or
more episodes has also been reported [4]. Otitis media
can, however, lead to serious complications, including
death [5]. Heritability studies-for example, twin and
triplet studies-suggest that otitis media has a significant
genetic component [6]. Therefore, studying the causes
of otitis media must include exploration of the genetic
factors involved.
Otitis media can be caused by Eustachian tube dys-
function due to anatomical blockage or mucocilliary
dysfunction [1]. Alternatively, it can be caused by more
systemic factors, such as immune dysfunction, healing
or complications from a bacterial load that cannot be
cleared adequately. Genes affecting any of these pro-
cesses may cause or predispose to otitis media, meaning
that patients affected by variation in one gene may all
show otitis media, while variation in another gene may
result in only some patients displaying otitis media [7].
Otitis media may be acute (short-lived) or chronic (long
lived). Chronic otitis media can also be divided by
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otitis media (where the tympanic membrane is affected,
usually being perforated) or chronic otitis media with
effusion (where the tympanic membrane is normal) [8].
Here we report the identification of a new N-ethyl-N-
nitrosourea (ENU)-induced mutation, dearisch, in the
m o u s eb ye x o m es e q u e n c i n g .E N Ui sac h e m i c a lm u t a -
gen that, when injected into male mice, mutagenizes
spermatogonia, resulting in random point mutations.
The dearisch mutant arose from a large scale ENU
mutagenesis program looking for new dominant muta-
tions causing hearing loss by screening the first (F1)
generation of offspring from ENU-exposed male mice
[9]. Previous reports have shown ENU mutants to be a
rich source of mouse models of otitis media [10-12]. For
example, the Jeff mouse mutant shows fully penetrant
c h r o n i cp r o l i f e r a t i v eo t i t i sm e d i aa n dam u t a t i o ni nt h e
Fbxo11 gene was identified as being causative. In this
case, outcross/backcross mapping followed by sequen-
cing of the locus was used to identify the causal muta-
tion [13]. Fbxo11 has since been shown to affect the
TGF-b pathway [14] and susceptibility to otitis media
associated with mutations in this gene have been
reported in humans [15]. Another example is the Junbo
mutant, which carries a mutation in the Evi1 gene. This
mutant exhibits acute otitis media leading to chronic
suppurative otitis media in most mice [11].
Genetically induced propensity to spontaneous chronic
otitis media has been studied in several other mouse
mutants, including those with mutations in the genes
Fgfr1 [16,17], Trp73 [18], Nfkb [19], E2f4 [20], Eya4
[21], Nf2 [22], Plg [23], Tbx1 [24], Rpl38 [25] and Scx
[26]. Mutations in the genes Sall4 [27], Sh3pxd2b [28]
and Phex [29] have also been implicated in otitis media
in mice, but have not been fully characterized. Muta-
tions that lead to immune or autoimmune conditions
can also increase susceptibility to otitis media following
exposure to bacteria, such as in Tlr2 [30], Tlr4 [31,32],
Myd88 [33], Ticam1 [34] and Fas [35] mutants. Genes
that lead to ciliary defects, such as Gusb [36], Idua [37],
Naglu [38], Cby1 [39] and Dnahc5 [40], among others,
are known to lead to spontaneous chronic otitis media.
As in humans, trisomy 21 can lead to otitis media in
mouse mutants, such as Ts65Dn [41]. In humans many
candidate genes have also been identified that are sus-
pected of leading to otitis media, including FBXO11
[15], SMAD2, SMAD4, TLR4 [42], MUC5AC [43], IL6
[44], IL10, TNFa [45], TGF-b1, PAI1 [46], MLB2, G45D
[47], SP-a1 6A [48], CD14 [49], IFNg [44], HLA-A2 [50],
HLA-A3, G2m(23) [51] and more.
Identification of mutations causing a phenotype in
ENU-induced mouse mutants has traditionally
included mapping of backcross progeny to identify the
mutated gene. Although this approach has been
successfully used to identify many fully penetrant
mutations, it requires a reasonable number of affected
offspring and is difficult in mutants with low pene-
trance. Exome sequencing has been successfully used
to identify mutations causing genetic conditions in
human families despite small pedigrees [52,53]. The
use of exome sequencing in mice obviates the need for
backcross mapping and is therefore an ideal tool to
identify mutations in mutants having complex and/or
partially penetrant phenotypes.
The mouse mutant discussed in this paper, dearisch
(Drsh), was discovered to gradually lose the Preyer reflex
(earflick in response to sound), suggesting hearing loss.
We report that the low penetrance hearing impairment
of dearisch mutants is associated with chronic otitis
media and by using exome sequencing we have identi-
fied the likely causative mutation in the gene Islet 1
(Isl1).
Results and discussion
Dearisch mice show impaired auditory responses and
middle ear inflammation
We distinguished affected mice in the dearisch colony
by auditory brainstem response (ABR) threshold mea-
surements. Mice display a range of ABR thresholds to
click stimuli, from normal (approximately 15 to 30 dB
sound pressure level (SPL)) to moderate hearing impair-
ment (between 50 and 80 dB SPL), with a bimodal dis-
tribution (n = 250; Figure 1a). Affected mice were
defined as having a click threshold of 50 dB SPL or
over, and mice with click thresholds of 30 dB SPL or
below were defined as unaffected mice. Measurements
of thresholds at a range of frequencies at 12 weeks old
showed approximately 40 dB hearing loss across the
majority of frequencies in affected mice (Figure 1b).
This consistent loss across frequencies, mirroring the
shape of the audiogram in unaffected, hearing mice,
associated with a hearing loss of rarely more than 40 dB
and normal growth of waveform amplitudes and reduc-
tion in latencies with increasing stimulus intensity above
threshold (Figure 1c, d), are all consistent with conduc-
tive pathology as the most likely cause for the hearing
impairment.
Repeated ABR testing on a cohort of aging mice
demonstrated that affected dearisch mice have hearing
impairment from the earliest age tested (3 weeks), and
this surprisingly does not generally progress with age
(Figure 1e).
Gross anatomy of the inner ear appears normal (Fig-
ure 2a-d) and the round and oval window areas are not
significantly different between unaffected and affected
mice (Student’s t-test; P-value 0.24 and 0.86, respec-
tively; data not shown). Ultrastructural anatomy of the
cochlea assessed using scanning electron microscopy
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Figure 1 Auditory brainstem responses in dearisch mice. (a) The distribution of click thresholds of mice in the dearisch colony born
between 2009 and 2011 (n = 250). The majority of mice hear normally; however, there is a second peak of mice with a spread of thresholds
between 50 and 80 dB SPL. (b) The audiograms of mice examined with the long ABR protocol at 12 weeks of age (n = 16). The mean
thresholds at each frequency and standard deviation at each frequency for the mice with an ABR click threshold above 50 dB SPL (affected) and
below 30 dB SPL (unaffected) are shown in red and blue, respectively. The shape of the mean affected audiogram is similar to the unaffected
audiogram with approximately 40 dB increase in threshold (hearing loss) at each frequency, consistent with a conductive hearing impairment.
(c) Growth of ABR wave 1 amplitude with increasing stimulus intensity, plotted as dB above threshold (sensation level, dB SL), is similar in
affected and unaffected mice, consistent with a purely conductive defect; n = 13 affected mice (in red) and 13 unaffected mice (in blue). (d)
Reduction in latency to the first peak of the ABR waveform with increasing stimulus intensity above threshold (dB SL) is similar in affected and
unaffected mice, consistent with a conductive defect; n = 13 affected mice (in red) and 13 unaffected mice (in blue).(e) Measurement of click-
evoked ABR thresholds with recovery allowing repeated ABR measurements in individual mice with increasing age from 3 to 28 weeks. From 8
to 28 weeks 16 mice underwent recurrent recordings and 9 mice underwent single recordings. Between 3 and 8 weeks a different set of mice
(n = 66) underwent one or two click ABR recordings. Although there is some variability in thresholds, most mice could hear normally, while a
few mice have raised thresholds from as early as 3 weeks. In general, thresholds are stable, not increasing with age.
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Page 3 of 19shows normal sensory hair cell morphology and layout
(Figure 2e-j).
However, middle ear examination revealed chronic
otitis media with an intact tympanic membrane (Figure
3). Affected mice displayed a variety of pathological fea-
tures associated with otitis media, including: white bony
bulla instead of translucent bone (12 of 14); an abnor-
mally vascularized bulla (5 of 14); a vascularized tympa-
n i cm e m b r a n e( 5o f1 4 ) ;f l u i di nt h em i d d l ee a r - m o s t l y
thick, white, opaque, but not sticky fluid (11 of 14);
mucosal oedema (6 of 14); crystalline deposits around
the malleus (6 of 14); bony outgrowths that sometimes
included fusion of ossicles (9 of 14); and excessive ceru-
men in the external ear canal (12 of 14). The severity of
otitis media was variable and this may account for the
variability of the ABR findings. The ABR thresholds did
not fluctuate substantially in most individual mice over
time (Figure 1c), implying the hearing impairment is
due to chronic middle ear disease rather than recurrent
acute otitis media. Middle ears of unaffected mice with
normal click thresholds were not entirely normal, and
showed some abnormal signs, including: a white bony
bulla (2 of 14); a vascularized bulla (1 of 14); a vascular-
ized tympanic membrane with engorged capillaries (1 of
14); fluid in the middle ear, either clear or turbid (4 of
14); edema of the middle ear lining (1 of 14); crystalline
deposits (4 of 14); bony overgrowths (2 of 14); and ceru-
men in the external auditory canal (5 of 14). Mild and
less frequent pathology in mice with normal thresholds
is not entirely unexpected, as the apparent reduced
penetrance of the phenotype means some hearing mice
will carry the mutated gene and may exhibit some fea-
tures of otitis media without this being severe enough to
compromise ABR thresholds.
Histology of normally hearing mice revealed a single
cell thick mucosa lining the middle ear, while in affected
mice there was evidence of thickened mucosa with
fibrocytes, granulocytes and granulation tissue (Figure
4). This is typical of chronic otitis media. The middle
ear cavity of affected mice contained cellular effusion
including foamy macrophages and neutrophils, suggest-
ing an acute, possibly infective, otitis media superim-
posed upon the chronic otitis media. While no
unaffected mice grew any bacteria on culture of external
Figure 2 Inner ear in dearisch mice (a-d) Inner ears show no sign of abnormal gross morphology: (a, b) unaffected mouse; (c, d)
affected dearisch mouse. (a, c) Inner ear viewed from the middle ear side. (b, d) Inner ear viewed from the brain side. The leftwards-pointing
arrowhead indicates the round window and the rightwards-pointing arrowhead indicates the oval window; CC, common crus; Co, cochlea; L,
lateral semicircular canal; P, posterior semicircular canal; S, superior semicircular canal. (e-j) Scanning electron microscopy at 50% of the distance
along the length of the organ of Corti showing normal ultrastructure: (e-g) from unaffected mouse; (h-j) from affected dearisch mouse. (e, h)
Normal organ of Corti layout with three rows of outer hair cells and one row of inner hair cells. (f, i) Outer hair cells with a normal morphology.
(g, j) Normal inner hair cells. The whole length of the organ of Corti was examined at 10% intervals and no abnormalities were detected (data
not shown). Scale bars: 1 mm (a-d); 10 μM (e, h); 1.5 μm (f, g, I, j).
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Page 4 of 19Figure 4 Hematoxylin and eosin staining of the middle ear in adult mice. (a, b) The middle ear of an unaffected animal. This has a clear
middle ear cavity (MEC), external auditory canal (EAC) and a thin, single cell mucosal lining of the cavity. (c, d) An affected animal with a
normal EAC, but effusion within the MEC and a thickened mucosa, with fibroblasts, granulocytes and granulation tissue. (e) A magnified view of
the effusion in an affected animal, containing foamy macrophages and neutrophils. M, malleus. Scale bars: 100 μm (a, c); 20 μm (b, d, e).
Figure 3 Histology of the middle ear. (a) A normal unaffected translucent bulla in an unaffected animal. (b) An abnormally white bulla with a
small engorged capillary (indicated by the arrowhead) from an affected animal. (c) An unaffected animal with a normal transparent tympanic
membrane and the malleus (M) and incus (Inc) visible beneath. (d) The tympanic membrane is opaque with engorged capillaries on the surface
(indicated by arrowheads). This animal also showed raised ABR thresholds. (e) A normal malleus from an unaffected animal. (f) A malleus (M)
with fused incus (Inc) and extraneous bony growth on the malleus head and manubrium (Man) from an affected animal. This represents the
most extreme example of extraneous bony growth. (g) Crystalline deposits found in the middle ear cavity of an affected animal. Scale bars: 1
mm (a, b); 0.5 mm (c-f); 0.2 mm (g).
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Page 5 of 19and middle ear swabs, two out of four affected mouse
middle ears and one out of four of their external ear
canals grew Proteus sp. (DJ Pickard, personal
communication)
Autosomal dominant inheritance with reduced
penetrance of hearing impairment
The current dearisch colony is derived from a single
male on a C3HeB/FeJ background. This original founder
male had mild hearing loss (click threshold 34 dB SPL)
on ABR, suggesting variable expressivity of the muta-
tion. When crossed with known wild-type females from
the original C3HeB/FeJ background, the male produced
some mildly and some moderately affected offspring in
the F1 generation, suggesting dominant inheritance. The
male was able to produce both affected male and female
progeny, suggesting that X-linked inheritance is unlikely.
The colony has been outcrossed at least five times to
wild-type mice from a C3HeB/FeJ colony that had not
been exposed to ENU, diluting out ENU-induced muta-
tions that are unrelated to the dearisch phenotype.
There were smaller numbers of affected mice in the col-
o n yt h a nc o u l db ee x p l a i n e db yas i m p l eM e n d e l i a n
model with full penetrance.
We attempted to map the mutation by outcrossing an
affected male to C57BL/6J females, then backcrossing
affected outcross offspring to known wild-type C57BL/
6J mice. Five affected outcross mice were found out of
168 tested, but when these were backcrossed there were
no affected backcross offspring out of 77 tested so we
were unable to map the mutation by the usual linkage
analysis approach.
Exome resequencing identifies an Isl1 missense mutation
We used the Agilent SureSelect
XT mouse all exon kit
for sequence capture followed by Illumina Genome
Analyzer II next-generation sequencing to search for the
causative mutation using one DNA sample from an
affected dearisch mouse and one sample from the
C3HeB/FeJ colony (Table 1). Agilent reports 49.6 Mb
capture of 221,784 exons from 24,306 genes using this
kit [54]. Sequencing reads were mapped to NCBI build
37 of the mouse genome (C57BL/6J) using bwa 0.5.7
[55] and duplicate fragments were marked using picard
1.15 [56]. SAMtools 0.1.8 [57] was used to obtain a list
of single nucleotide variants (SNVs) and short insertions
and deletions. These were filtered to remove variants
found in both wild-type (C3HeB/FeJ) and dearisch
mutant sequences, and then to remove variants known
to be present in other strains, from dbSNP (build 128
[58]) [59] and from the resequencing of 17 inbred
strains [60] (Table 2). Variants were finally filtered on
the basis of SNP quality (with a lower limit of 20), map-
ping quality (with a lower limit of 45) and read depth
(with a lower limit of 10). This resulted in approxi-
mately 8,000 variants. These were then prioritized on
the basis of type and consequence. Those SNVs that
were predicted to cause either the gain or loss of a stop
codon, that resulted in an amino acid change in the pro-
tein or that were within an essential splice site (defined
as being in the first or last two base pairs of an intron)
were chosen for further analysis. There were 23 SNVs
that fitted these criteria (Tables 2 and 3).
Of the 23 variants of interest, all were autosomal and
14 were present as heterozygotes, consistent with the
expected autosomal dominant pattern of inheritance. All
23 variants were analyzed further by capillary sequen-
cing using the original two DNA samples, which
resulted in exclusion of most of the variants as false
positive variant calls on the basis that the DNA sample
from the mutant DNA was identical to that of the wild-
type C3HeB/FeJ DNA at that position (Table 3). The
high number of false positives is due partly to the pre-
sence of small inserts or deletions causing the SAMtools
SNP caller to misread SNVs either side of the indel.
Most of the other false positives can be seen to have
low consensus and/or SNP quality scores for either or
both dearisch and C3HeB/FeJ sequences; SNVs were
not filtered on consensus score at all, and only lightly
on SNP quality score, becausew ep r e f e r r e df a l s ep o s i -
tives to false negatives. Only one SNV has high consen-
sus quality, SNP quality, mapping quality and read
depth scores, and this has been found by capillary
sequencing to be a correct call. This SNV is a point
mutation in Isl1 leading to a T to C base pair transition
at position MMU13:117098488 causing a substitution of
Table 1 Details of exome sequencing results
Sequencing details C3HeB/FeJ Dearisch
Type of sequencing Paired end Paired end
Read length 76 bp 76 bp
Number of reads mapped 96603761 96517342
Mean depth 126.24× 125.97×
Coverage of bases in Agilent exons 99.71% 99.68%
Coverage of bases in Agilent exons to a depth of 10 fold or more 98.28% 98.05%
Coverage of bases in Agilent exons to a depth of 20 fold or more 95.63% 95.17%
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Page 6 of 19tyrosine by cysteine (Y71C; Figure 5a, b). This missense
mutation affects an amino acid within the first LIM
domain of Isl1.
Capillary sequencing of this position in 21 wild-type
strains and in 5 individual C3HeB/FeJ wild-type mice
reveals that all are homozygous (T/T) for the reference
allele. Indeed, this T to C transition in dearisch mutants
a l t e r sat y r o s i n er e s i d u et h at is highly conserved in
orthologous proteins in other species (Figure 5c, d).
Having detected this promising candidate mutation, we
sequenced DNA samples from throughout the dearisch
colony. All 28 affected dearisch mice (born between
2009 and 2011) were heterozygotes (T/C). All of the
mice with thresholds above 50 dB SPL were found to
have one copy of the Isl1 mutation (Table 4). Of the off-
spring of known heterozygote by heterozygote matings,
no pups out of 111 were detected as homozygous for
the Isl1 mutation, suggesting severely reduced homozy-
gote viability. The penetrance of raised ABR thresholds
(> 50 dB SPL) in known heterozygotes is 23.1%. Inter-
estingly, most of the mice with ABR click thresholds of
30 to 50 dB SPL were also heterozygous for the dearisch
Isl1 mutation (Table 4; Figure 6), giving a penetrance of
51.2% if the more mildly affected mice are included.
Furthermore, most of the ‘unaffected’ mice with thresh-
olds of 30 dB SPL or less but with signs of subclinical
middle ear inflammation mentioned earlier were found
to be carriers of the Isl1
Drshmutation (data not shown).
The close linkage of the Isl1 variant with the otitis
media phenotype is strong support for this being the
causative mutation. However, it remains a possibility
that the Isl1 variant is simply a linked marker. In order
to exclude linkage between the Isl1 mutation and any
other potentially causative mutation, it is important to
exclude other mutations on chromosome 13 (Table 5).
Of the 23 SNVs (non-synonymous, stop gained and
splice site mutations) identified by exome sequencing,
the Isl1 mutation is the only one on chromosome 13
(Table 3). Four other chromosome 13 SNVs were
excluded at the final filtering step, one in a noncoding
transcript of Tpmt,o n ei nt h e5 ’ UTR of Smad5 and
two in the 3’ UTRs of the genes Histh1a and Sdha,t h e
closest of which is 70 Mb from the Isl1 mutation. We
also examined indels from chromosome 13. The SAM-
tools variant caller identifies short indels as well as
SNVs, and these indels were not included in the final
analysis of 23 variants. Thirteen deletions and twelve
insertions were identified on chromosome 13, although
only one and five, respectively, were within coding
regions. Of the insertions and deletions within 10 Mb of
Isl1, none were within coding regions.
Isl1 is expressed in the middle ear
We next asked if Isl1 protein is expressed in the middle
ear. Immunohistochemistry of the adult wild-type mid-
dle ear revealed clear, widespread expression of Isl1
within the single cell mucosal lining of the middle ear
cavity, including the single cell layer covering the ossi-
cles, but less pronounced on the inner surface of the
tympanic membrane (Figure 5e, f). Expression is also
seen in the epithelial layer of the external ear canal and
outer layer of the tympanic membrane. At postnatal day
4, the expression is more diffuse but is present in the
immature mucosa where the middle ear has cavitated
and in the outer cellular layer surrounding the ossicles
(Figure 5g).
Modeling the consequences of the Y71C missense
mutation on protein structure
According to Pfam [61], the Isl1 protein consists of four
Pfam domains: two LIM domains, a homeodomain and
a Gln-rich domain. Each LIM domain contains two zinc
fingers, which each bind a zinc atom. The LIM-homeo-
domain (LIM-HD) combination is thought to represent
a ‘LIM code’ that governs transcriptional regulation in
the control of cell type specification in different tissues
and organs [62]. Isl1 is a member of the LIM-HD family
of proteins. The two LIM domains are responsible for
interaction with other proteins while the homeodomain
uses its helix-turn-helix motif to bind DNA sequences
containing the sequence 5’-ATTA-3’ and so initiate
transcription of the appropriate genes.
Proteins binding to LIM-HD proteins do so via a
LIM-interaction domain (LID), which consists of around
30 residues. The Y71C mutation is located within the
first LIM domain and so may affect the strength of this
binding. To predict how it might do so requires knowl-
edge of the protein’s three-dimensional structure.
To date, there have been no experimental determina-
tions of the three-dimensional structure of Isl1 protein
(other than fragments of the carboxy-terminal domain).
However, there are many structural models of related
proteins in the Protein Data Bank (PDB) [63]. One of
Table 2 Filtering of exome sequence data to identify the
mutation in Isl1
Processing steps Number of DNA
changes
Different from the C57BL/6J reference
sequence (C3H/Drsh)
7261538/7242100
C3H not same as Drsh 5022723
Not in dBSNP and 17 wildtype strains 3654870
Samtools quality filter 76264
Mapping quality > 45 and read depth > 10 7980
Remove intronic and intergenic variants 1260
Select stop, nonsynonymous and splice
site SNVs
23
Confirm with capillary sequencing 1
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Page 7 of 19Table 3 Details of the 23 SNVs analyzed further after filtering of exome sequence data
Dearisch C3HeB/FeJ
Gene name Location Predicted DNA change Reference
(C57BL/6J)
Consensus Genotype Consensus
quality
SNP
quality
Mapping
quality
Read
depth
Consensus Genotype Consensus
quality
SNP
quality
Mapping
quality
Read
depth
Cap
seq
C3H
Cap
seq
Drsh
Comments
1700001K19Rik 12:111907080 Nonsynonymous: H:L T A Hom 20 51 58 63 T/A Het 72 134 55 73 Deletion Deletion Misalignment
around deletion.
1700104B16Rik 8:34841236 Nonsynonymous: H:D G G/C Het 76 76 55 54 G Hom 9 0 52 58 G/C G/C The dearisch read
is correct; the
incorrect C3H read
has a very low
consensus score
Acsl3 1:78692680 Stop gained C A Hom 7 25 49 16 A/C Het 9 9 56 15 C C Deep sequencing
miscalled an A in
Drsh and a C/A
het in C3H. Neither
of them have high
consensus or SNP
quality scores
Bcl2l14 6:134377474 Nonsynonymous: N:K T G Hom 3 36 50 64 G/A Het 9 10 60 61 NA Deletion Misalignment
around deletion;
low quality
consensus and
SNP scores
Btnl7 17:34670007 Nonsynonymous: G:R C C/T Het 6 96 48 30 T Hom 96 141 53 44 C/T C/T The C3H read has
been miscalled as
a homozygote
Catsper2 2:121223476 Nonsynonymous: N:D T C Hom 33 33 47 83 T/C Het 15 28 44 86 Deletion Deletion Misalignment
around deletion
Col6a3 1:92672331 Essential splice site C G Hom 30 30 60 16 A Hom 33 33 29 18 NA Deletion Misalignment
around deletion
Creb3l2 6:37284584 Essential splice site T C/T Het 38 38 54 23 T Hom 11 0 56 18 T T The dearisch read
has been miscalled
as a heterozygote
Gm10859 2:5833494 Nonsynonymous: I:V A A/G Het 41 48 56 18 A Hom 39 0 41 17 Deletion Deletion Misalignment
around deletion
Gm11149 9:49380322 Nonsynonymous: Q:P A C Hom 0 36 54 30 G/C Het 0 23 52 30 Deletion Deletion Misalignment
around deletion
and low quality
consensus scores
Gtf3c2 5:31476808 Nonsynonymous: E:G T C/T Het 25 25 49 39 T Hom 33 0 52 30 T T The dearisch read
has been miscalled
as a heterozygote.
Its consensus and
SNP quality scores
are low
H2-Oa 17:34229420 Nonsynonymous: V:A T C/T Het 3 35 48 86 T Hom 39 0 46 79 Deletion Deletion Misalignment
around deletion
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9Table 3 Details of the 23 SNVs analyzed further after filtering of exome sequence data (Continued)
Ido1 8:25703857 Nonsynonymous: R:K C C/T Het 21 21 50 30 C Hom 13 0 53 39 C C The dearisch read
has been miscalled
as a heterozygote.
Its consensus and
SNP quality scores
are low
Isl1 13:117098488 Nonsynonymous: Y:C T C/T Het 199 228 60 66 T Hom 223 0 60 65 T C/T Confirmed by
capillary
sequencing
Mdc1 17:35984844 Nonsynonymous: E:D G T Hom 13 39 50 11 G/T Het 21 21 55 11 G G Deep sequencing
miscalled a G as a
Ti nDrsh and a G/
T het in C3H.
Neither of them
has a very high
consensus quality
score
Olfr424 1:176066876 Essential splice site A G/T Het 4 58 58 88 T Hom 6 60 60 88 Insertion A Misalignment
around insertion,
also low consensus
quality scores
Olfr573-ps1 7:110091057 Nonsynonymous: H:Q G T Hom 21 25 56 82 G/T Het 33 34 56 96 Deletion Deletion Misalignment
around deletion
Olfr573-ps1 7:110091058 Nonsynonymous: H:L T A Hom 22 45 53 79 T/A Het 8 62 57 96 Deletion Deletion Misalignment
around deletion
Olfr749 14:51356853 Nonsynonymous: Q:K G G/T Het 36 36 46 81 G Hom 17 0 39 62 Deletion Deletion Misalignment
around deletion
Rsf1 7:104809403 Nonsynonymous: E:Q G G/C Het 17 22 54 47 G Hom 42 0 55 45 Deletion Deletion Misalignment
around deletion
Rsf1 7:104809404 Nonsynonymous: E:V A A/T Het 14 22 54 47 A Hom 42 0 55 45 Deletion Deletion Misalignment
around deletion
Sap30 bp 11:115825338 Nonsynonymous: A:T G A/G Het 31 31 55 61 G Hom 40 0 55 52 G G The dearisch read
has been miscalled
as a heterozygote
U1 1:172958261 Essential splice site T A/T Het 18 105 51 69 A Hom 26 75 51 58 Deletion Deletion Misalignment
around deletion
Capillary sequence results for the C3HeB/FeJ and dearisch DNA samples and comments on the reason for each false call are shown in the rightmost three columns. Fourteen of the calls were due to insertions or deletions
present at that location that were identical in the two DNA samples, and the original call was due to different nucleotides affected by the deletion being called in the two samples. Het, heterozygous; Hom, homozygous; NA,
sequence not available. Only one SNV was confirmed to be present in dearisch and not in C3HeB/FeJ or the C57BL/6J reference sequence, that in Isl1.
H
i
l
t
o
n
e
t
a
l
.
G
e
n
o
m
e
B
i
o
l
o
g
y
2
0
1
1
,
1
2
:
R
9
0
h
t
t
p
:
/
/
g
e
n
o
m
e
b
i
o
l
o
g
y
.
c
o
m
/
2
0
1
1
/
1
2
/
9
/
R
9
0
P
a
g
e
9
o
f
1
9(a)
(b)
(c)
MEC
(e) (d)
MEC
MES M
(f) (g) (f)
MEC
EAC
M
Mouse (Drsh)  ATACCTGATACAATCTCTTTT
Mouse (wildtype)  ATACCTGATATAATCTCTTTT
Rat  ATACCTGATATAATCTCTTTT
Human              ATACCTGATATAATCTCTTTT
Cat  GTACCTGATATAATCCCTTTT
Dog  GTACCTGATATAATCTCTTTT
Platypus  GTACCTGATATAATCTCTTTT
Chicken  GTACCTGATATAATCTCTTTT
Frog  TACCTGATATAGTCCCTTTT 
Zebrafish TACCTGATGTAGTCCCGTTT 
Figure 5 Islet1 sequence analysis and expression in dearisch mice. (a, b) In the wild-type original background mouse, capillary sequencing
confirmed a T/T residue (a), while in affected animals C/T was found (b). No homozygote mutants were identified, suggesting homozygote
lethality. (c) The thymine base indicated in red was conserved among the species shown and also in giant panda, guinea pig, cow, sloth,
armadillo, hedgehog, horse, gorilla, African elephant, mouse lemur, opossum, rabbit, chimp, hyrax, brown bat, common shrew, wild boar, puffer
fish, bush baby, dolphin and alpaca (sequences obtained from Ensembl [88]). (d) Using ConSurf [89] the tyrosine amino acid residue (indicated
by a blue arrow) was found to have a high conservation score of 8, and was predicted to be buried (green letter ‘b’) rather than exposed
(orange letter ‘e’). It is not noted as being either structural (blue letter ‘s’) or functional (red letter ‘f’); however, it is next to a highly conserved,
exposed, functional residue and therefore may be important in positioning this residue. (e) Immunohistochemistry using Isl1 antibody indicates
expression (brown) within the mucosal lining of the middle ear cavity (MEC) in wild-type adult mice. (f) Immunohistochemistry showing Isl1
labeling in the cell layer covering the malleus (M) and the outer layer of the tympanic membrane, adjacent to the external auditory canal (EAC)
in the wild-type adult. (g) Immunohistochemistry showing more diffuse Isl1 labeling in the cell layer over the malleus at postnatal day 4. The
middle ear is still largely filled with mesenchyme (MES) at this early stage. Scale bar: 20 μm (e, f); 40 μm (g).
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Page 10 of 19these, PDB entry 2xjy, is of particular interest. This is a
structural model, solved by X-ray crystallography to 2.4
Å resolution, of human rhombotin-2 (aka LMO2). The
protein is a LIM-only (LMO) protein; that is, it consists
of two LIM domains only. However, the structure is a
complex between this protein and a 35-residue fragment
of a LID from human LIM domain-binding protein 1.
As such, it provides a general idea of how LIM domains
recognize their interaction partner. The three-
dimensional structure reveals that the LID fragment
b i n d si na ne x t e n d e dc o n f o r m a t i o na l o n gag r o o v er u n -
ning along the length of the two LIM domains.
Thus, to help understand the structural effects of the
Y71C mutation, we built a homology model for Isl1,
using the rhombotin-2 protein from PDB entry 2xjy as a
template. The sequence identity of the two LIM
domains in the two proteins is 34% over 126 residues,
giving an E-value of 9 × 10
-32, so the model is expected
to be a good approximation of the structure of Isl1. Fig-
ure 7 shows the model, with the LID from PDB entry
2xjy retained to show the interactions that one might
expect between the LIM domains of Isl1 and the LIDs
of the protein(s) they bind to. Of particular interest is
Tyr71. The equivalent of this residue in the PDB 2xjy
structure is Tyr84. This makes a side chain-side chain
hydrogen bond with Asp354 in the LID of the partner
protein. It turns out to be the only side chain-side chain
hydrogen bonded interaction across the interface
between the two proteins. In all, 12 pairs of residues
interact via hydrogen bonds across this interface and all
but the Tyr84-Asp354 interaction are hydrogen bonds
b e t w e e nm a i nc h a i na t o m s .S om u t a t i o n st oa n yo f
these other residues are far less likely to disrupt the
binding of the two proteins. Indeed, it seems to be a fea-
ture of the LID-LIM interface that it is particularly tol-
erant to mutation [64]. The exception would appear to
be the Tyr84-Asp354 interaction.
Role of Isl1 in middle ear function
We propose that the Isl1 Y71C mutation leads to the
predisposition of heterozygotes to develop otitis media,
for several reasons. Following exome resequencing, the
Isl1 variant was the only candidate that was confirmed
by capillary sequencing. The tyrosine residue at this
location is highly conserved among many species and in
other mouse strains. The Isl1 mutation segregates with
the phenotype, with all affected mice carrying the muta-
tion in heterozygote form. No other likely pathogenic
DNA changes linked to Isl1 on chromosome 13 were
identified. Isl1 is expressed in the middle ear mucosa of
wild-type mice. Finally, three-dimensional modeling of
LIM domain interactions pinpoints the amino acid
altered by this mutation as being particularly important
in protein-protein interactions. As it was not possible to
map the locus of the causative gene in dearisch using
traditional backcross matings due to the low penetrance
of the phenotype, exome resequencing has proved to be
invaluable in identifying the likely causative mutation.
Isl1 is a transcription factor that acts as an insulin
enhancing gene [65]. It contains two LIM domains and
one carboxy-terminal homeodomain involved in pro-
tein-protein and protein-DNA interactions. Our model-
i n gs u g g e s t st h i sp r o t e i n - p r o tein interaction is likely to
Table 4 Analysis of offspring from dearisch matings
< 30 30 to 50 > 50 Total Percent
Het × Het
a
WT 37 (23/15) 2 (1/1) 0 (0/0) 39 35.10%
Het 32 (25/7) 21 (13/8) 19 (13/6) 72 64.90%
Hom 0 (0/0) 0 (0/0) 0 (0/0) 0 0.00%
Total 69 23 19 111
Percent 62.20% 20.70% 17.10%
Het × WT
b
WT 35 (19/16) 1 (1/0) 0 (0/0) 36 42.40%
Het 27 (15/12) 13 (8/5) 9 (6/3) 49 57.60%
Hom 0 (0/0) 0 (0/0) 0 (0/0) 0 0.00%
Total 62 14 9 85
Percent 72.90% 16.50% 10.60%
aThe genotypes and ABR click thresholds of mice from the dearisch colony
born to known heterozygote (Het) by heterozygote matings.
bThe genotypes
and click-evoked ABR thresholds of mice from the dearisch colony born to
known heterozygote by wild type (WT) matings. The number of mice in each
category is given, with number of males/number of females in parentheses.
Hom, homozygote.
Figure 6 Distribution of ABR click thresholds in the dearisch
colony divided by genotype for the Isl1
Drshmutation, showing
overlapping of heterozygotes (red) and wild types (blue) at
low thresholds and heterozygotes only with high thresholds.
Please note on the figure itself in the pdf sent previously (not
included in this file) that the legend in the box at the bottom left
has lost its red line indicating the heterozygote line.
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Page 11 of 19Table 5 Exclusion of potential linkage within 10 Mb of Isl1 (117098488) and on the remainder of chromosome 13
Gene name Position Reference Dearisch Type Location Zygosity Consequence (if in coding region)
a
Within 10 Mb of
Isl1
Ipo11 107700899 * -T/* Deletion Splice site
(intronic)
Het
Kif2a 107752127 * */-G Deletion 3’ UTR Het
Slc38a9 113523874 * -TT/-TT Deletion 5’ UTR Hom
Gzmk 113963370 * */+T Insertion Splice site Het
On remainder of
chromosome 13
Pfkp 6604227 * */+GG Insertion Exonic Het Frameshift leading to truncation of protein in
exon 10 (approximately half its length)
Gtpbp4 8984980 * */-A Deletion Splice site
(intronic)
Het
Pgbd1 21515496 * -AGGAA/-AGGAA Deletion Splice site
(intronic)
Hom
Isca1 21587150 * */-GGCTGCGG Deletion 5’ UTR Het
Hist1h1c 23831772 * +TN/+TN Insertion 3’ UTR Hom
Hist1h1a 23856249 A A/C SNP 3’ UTR Het
Agtr1a 30473986 * */-T Deletion 3’ UTR Het
Txndc5 38599758 * */-A Deletion Splice site
(intronic)
Het
Gm9979 40801514 * +CACACACACACG/
*
Insertion 3’ UTR Het
Tpmt 47135375 A A/T SNP Noncoding
(retained
intron)
Het
Iars 49829191 * */-TG Deletion 3’ UTR Het
Sema4d 51798481 * */+G Insertion Exonic Het Frameshift leading to truncation of protein in
last exon
Cdhr2 54827830 * */+G Insertion Exonic Het Frameshift leading to truncation of protein in
exon 19 (approximately two-thirds of its
length)
Smad5 56824847 * */+CACACACACACA Insertion 5’ UTR Het
Smad5 56824796 C C/T SNP 5’ UTR Het
Klhl3 58165232 * -GA/-GA Deletion Splice site
(intronic)
Hom
Ptch1 63613020 * */+A Insertion Exonic Het Frameshift leading to truncation of protein
very close to carboxyl terminus
1110018J18Rik 64393367 * +A/* Insertion 3’ UTR Het
Sdha 74460494 T G/T SNP 3’ UTR Het
Spata9 76115351 * -C/-C Deletion Exonic Hom Frameshift leading to incorrect final 15
amino acids and loss of stop codon
Fam81b 76408769 * +TTA/+TTA Insertion Exonic Hom Gain of stop codon leading to truncation of
protein after 15 amino acids
Rasa1 85370111 * +G/+G Insertion Noncoding
(retained
intron)
Hom
Rasgrf2 92024132 * -A/-A Deletion Splice site
(intronic)
Hom
Pde8b 95822955 * */-TAA Deletion Noncoding
(retained
intron)
Het
Bdp1 100808235 * */+A Insertion Splice site
(intronic)
Het
aPredicted consequences are shown where the mutation lies in a coding region. Plus signs indicate insertion; minus signs indicate deletion. *Asterisks indicate
the presence of the wildtype reference sequence where an insertion or deletion has been called in the dearisch sequence. These calls have not been confirmed
by capillary sequencing.
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Page 12 of 19have been interrupted by the mutation we discovered in
dearisch mutants. Isl1 has one isoform in mice and
seven isoforms in humans and is located on chromo-
somes 13 and 5, respectively. Several mouse mutations
affecting Isl1 exist, and the most widely studied is the
Isl1
tm1Tmj allele [66], which consists of a neo cassette
insertion into the DNA sequence encoding the second
LIM domain. Mice with this mutation are homozygote
lethal at embryonic day (E)11.5. Dearisch also appears
to be homozygote lethal, although the age and cause for
this has yet to be determined. Of four embryos so far
harvested from dearisch heterozygote by heterozygote
matings at E9.5, one has been genotyped as a homozy-
gote. This pup looked immature and abnormal on exter-
nal inspection (data not shown). Homozygotes of
Isl1
tm1Tmjexhibit malformed vasculature, including the
dorsal aorta, foregut and pancreatic malformations, and
exhibit no motor neuron development. Heterozygote
carriers of Isl1
tm1Tmjh a v en o tb e e nr e p o r t e dt oh a v ea n y
middle ear or inflammatory defects. However, Isl1 is
expressed in both immature cochlear hair cells and in
auditory neurons [67]. Over-expression of Isl1 results in
Isl1
LID
LIM1
LIM2
Isl1 other
LID
Zinc
Crucial interaction (b)
(a)
Figure 7 A homology model of ISL1 based on the three-dimensional structural model of human rhombotin-2 (PDB entry 2xjy), with
the fragment of the LID protein from PDB entry 2xjy retained. (a) A surface representation of the interacting proteins. The ISL1 protein
model is shown in white, while the LID protein is in red. (b) Secondary structure representation of the two proteins. The two LIM domains of
the ISL1 protein are colored yellow and orange, with the remainder of the protein shown in purple. The LID fragment is shown in red. The
crucial interaction between Tyr71 of ISL1 and Asp354 of the LID is shown by the stick representation of the two interacting side chains
(indicated by the blue arrow). The green spheres correspond to the zinc atoms bound by the zinc fingers of the LIM domains. The images were
generated using PyMol [90].
Hilton et al. Genome Biology 2011, 12:R90
http://genomebiology.com/2011/12/9/R90
Page 13 of 19protection of neurons from age-related and noise-
induced hearing loss [68]. No electrophysiological stu-
dies of inner ear function in Isl1 mutants have been pre-
viously reported. Surprisingly, despite evidence of
widespread neuronal irregularities in Isl1 knockout mice
a n dt h ek n o w ne x p r e s s i o no fI s l 1w i t h i nt h ei n n e re a r ,
no evidence of sensorineural abnormalities were
detected in the affected dearisch mice. This suggests
that one copy of the wild-type Isl1 allele is sufficient for
normal development of auditory neurons and hair cells.
Prior to this study, Isl1 expression in the middle ear
had not previously been reported. However, Isl1 expres-
sion has been documented within other mucosal epithe-
lial linings. Expression of Isl1 is strong in the
ultimobranchial epithelium of the pharynx at embryonic
stages [69], and was increased in specification of lung
bud at E8.5 to E9.5 [70]. Isl1 expression has been found
in somatostatin-expressing cells of the gastric mucosa in
juvenile rats, suggesting that Isl1 may have a role in reg-
ulating somatostatin gene expression [71]. In the lungs,
somatostatin is known to decrease substance-P-related
mucous secretion from submucosal glands [72]. This
suggests that Isl1 may affect mucous secretion from the
mucosa through effects on somatostatin. We found that
Isl1 is expressed in the wild-type adult middle ear
mucosa. This might be expected, as middle ear mucosa
is often described as being a respiratory-type mucosa.
Through secretion of protective factors such as lactofer-
rin, lysozyme and mucus, the middle ear mucosa can
reduce risk of infection [73]. Isl1 may contribute to pre-
disposition to otitis media by affecting the constituents,
amount or protective nature of middle ear mucosal
secretions.
The innate immune system offers non-specific
immediate defense against infection. The cytokines form
part of this system, recruiting immune cells and initiat-
ing or reducing inflammation by acting as chemical
mediators to specific genetic pathways. Interleukin 6 is
one such cytokine. It binds the gp130 component of the
type 1 cytokine receptor complex, resulting in activation
of the receptor, which initiates intracellular signaling.
JAK1 and STAT3 are known to be activated by this pro-
cess [74]. The JAK-STAT pathway is involved in acute
phase response and chronic inflammation in a variety of
tissues, including the lungs and gut [75]. Isl1 has been
shown to physically interact with both JAK1 and
STAT3, forming a complex in both human and monkey
immortal cell lines [76]. This results in the activation of
S T A T 3 ,w h i c ha c t sa sa ni m p o r t a n ts i g n a lt r a n s d u c e r
and activator of transcription. JAK1 is also activated and
is able to dock and recruit further signaling proteins.
STAT3 has been shown to be necessary for lung and
bladder epithelium to respond effectively to Gram-nega-
tive bacteria [77,78]. Without Isl1 the function of both
of these genes in the prevention of infection or inflam-
mation via innate immunity is potentially disrupted.
Like Isl1 mutants and dearisch, Stat3 knockout mice
suffer from embryonic lethality, while Jak1 knockout in
mice results in perinatal mortality [79].
The importance of innate immunity in reducing otitis
media is already well documented. For example, toll like
receptors (Tlrs) recognize bacterial endotoxin, stimulat-
ing TNFa production, which in turn affects production
of immunoglobulins, cytokines and mucin [46]. Mice
that are genetically deficient for Tlr4, such as the C3H/
HeJ inbred strain, develop chronic otitis media due to
an inability to clear Gram-negative bacteria [32].
Between 35% and 60% of these mice were affected by
otitis media at some point during their life span. Unlike
affected dearisch mice, there was also evidence of bony
remodeling of the round window and elements of inner
ear inflammation in some C3H/HeJ mice. Knockout of
gp130 suggests that the Tlr4 [31,32] pathway response
to bacterial endotoxin may be modulated by the Stat3
pathway [80]. The role of Isl1 in innate immunity is yet
to be fully elucidated, but wild-type Isl1 levels in hetero-
zygote dearisch mice may be sufficiently low to reduce
their ability to clear bacteria from the middle ear.
In humans, several rare point mutations in ISL1 have
been shown to lead to maturity onset diabetes of the
young [81]. An increased incidence of otitis media has
not been reported in people with mutations of this gene
but a general increased propensity to infection is well-
recognized in diabetics. Otitis media is very common
and therefore an increased prevalence of otitis media in
these patients may have gone unnoticed.
Conclusions
Dearisch mice are ENU-induced mutants that have a
predisposition to otitis media associated with a tyrosine
to cysteine missense mutation in Isl1. This results in
chronic otitis media with effusion associated with non-
progressive hearing impairment from 3 weeks of age.
Gross and microscopic inner ear anatomies are normal
and there is no evidence of sensorineural hearing
impairment, suggesting that decreased levels of wild-
type Isl1 do not affect inner ear function. The middle
ear of affected dearisch mice shows a thickened mucosa
and cellular effusion, while Isl1 is expressed in the nor-
mal middle ear mucosa. This suggests a previously
unknown role for Isl1 in middle ear function. Dearisch,
Isl1
Drsh, represents the first point mutation in the mouse
Isl1 gene and suggests a previously unrecognized effect
of this gene. This is also the first recorded sequencing
of the C3HeB/FeJ background common to many ENU
mutants and highlights the use of exome resequencing
in identifying mutations leading to low penetrance
phenotypes.
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Origin of the dearisch mutant
T h ef o u n d e rm o u s ew a sd e t e c t e di nal a r g e - s c a l eE N U
mutagenesis program aimed at detecting new dominantly
inherited phenotypes [9]. Impaired hearing was detected
by screening for lack of an earflick (Preyer reflex) in
response to a 20 kHz calibrated sound burst using a cus-
tom-made clickbox. Mice that did not respond were stu-
died in more detail. Affected dearisch mice (also known
as DEA2) appeared to lose their Preyer reflex from sev-
eral months of age. The colony was managed by mating
affected mice with unaffected littermates, and the line
was maintained on the original genetic background of
the mutagenized males, C3HeB/FeJ.
Auditory brainstem responses
ABRs were measured with recovery anesthesia using
three scalp electrodes [82]. Responses were recorded to
broadband clicks and tone bursts at 3, 6, 12, 18, 24, 30,
36 and 42 kHz and at a wide range of intensities from
10 to 97 dB SPL in 3 dB steps. Thresholds were deter-
mined using a stack of response waveforms and identi-
fying the lowest stimulus at which an identifiable
waveform occurs. This ABR protocol was performed
on 9 mice at single time points and 16 mice at 4-
weekly intervals from 8 to 24 weeks. Input/output
functions were then calculated using amplitude and
latency of P1/N1 and P4/N4 waveform components
plotted with respect to stimulus intensity (n = 13
affected and 13 unaffected mice at 3 to 15 weeks of
age).
A short ABR protocol taking approximately 6 minutes
per mouse, consisting of a 70 dB SPL test click, broad-
band clicks from 10 to 97 dB in 3 dB steps followed by
a further test 70 dB SPL click and anesthetic recovery,
was used to screen the entire colony (n = 85). Following
this, all mice born underwent this short ABR protocol
at 6 to 8 weeks of age (n = 348 in total) and the results
used to plan matings. However, only mice born between
2009 and 2011 (n = 250) were analyzed for constructing
frequency histograms to avoid bias due to selective
retention of affected mice born before 2009. Mice with
thresholds above 50 dB were defined as affected based
on the population distribution of click thresholds shown
in Figure 1a. This short ABR protocol was used to
assess younger mice from the dearisch colony at 3, 6
and 8 weeks of age (n = 66, with 35 mice undergoing
single recordings and 31 undergoing repeated ABR
measurements).
An outcross was performed with an affected dearisch
male and a female from the C57BL/6J inbred colony. F1
offspring (n = 168) were screened using the short ABR
protocol. Affected F1 mice were mated with another
C57BL/6J mouse to create a backcross. The backcross
offspring from these matings (n = 77) were screened
using the short ABR protocol.
A pedigree was drawn up using information from ABR
tests over several generations of the dearisch colony.
This has been combined with data from Isl1 genotyping.
Inner ear anatomy
Inner ear clearing was performed using glycerol as
described previously [83] (n = 5 affected and 5 unaf-
fected littermate controls, aged 15 months). Round and
oval window measurements were taken from images of
cleared inner ears using Adobe Photoshop. Each mea-
surement was performed four times and averaged. Scan-
ning electron microscopy (n = 3 affected and 3
unaffected littermate controls, aged 2 months) was per-
formed following fixation in 2.5% glutaraldehyde, a stan-
dard osmium-thiocarbohydrazide-osmium OTOTO
protocol, dehydration, critical point drying and examina-
tion in a Hitachi S-4800 scanning electron microscope.
Middle ear anatomy and immunocytochemistry
Middle ear dissections were performed on fresh tissue
(n = 14 affected and 14 unaffected littermate controls,
aged 9.3 to 24.0 months-mean 16.8 months, standard
deviation 4.2 months) and observations were recorded
on a standard tick sheet. First the tympanic membrane
was inspected, the tissue covering the bulla was dis-
sected away and the bulla inspected. The bulla was care-
fully removed and the tympanic membrane inspected a
second time. The tympanic membrane was removed and
t h ep r e s e n c eo ff l u i d ,i n f l a m e dm u c o s ao rd e b r i s
recorded. The malleus, incus and stapes were removed
and photographed before removing the inner ear for
clearing.
For histology, half heads of mice were fixed in 10%
formalin and decalcified using EDTA for 10 days. Fol-
lowing alcohol dehydration the half heads were
embedded in paraffin wax, sectioned to 8 μma n d
stained according to a standard hematoxylin/eosin pro-
tocol (n = 4 affected and 4 unaffected littermate con-
trols, aged 6 months). Isl1 expression was inspected on
sections from the same mice (n = 3 littermate controls,
aged 6 months) using Isl1 antibody (AbCam: 20670,
Cambridge, Cambridgeshire, UK) according to the
immunohistochemistry protocol described previously
[84]. Postnatal day 4 pups were also used for immuno-
histochemistry (n = 4 wild types), but no decalcification
step was required.
Bacteriology
Swabs from the outer and middle ear of affected and lit-
ter mate controls (n = 4 affected and 2 unaffected litter-
mate controls, aged > 15 months) were firstly grown on
nutrient broth and on L-agar plates (Oxoid Ltd,
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Page 15 of 19Basingstoke, UK). The bacteria were identified by plating
on selective media that included CLED, MaConkey’s and
UTI brilliance agar (Oxoid Ltd). Oxidase testing was
used as a final confirmatory step.
Exome sequencing and analysis of the Isl1 mutation in
the dearisch colony
One deaf dearisch mouse and one mouse of the origi-
nal background C3HeB/FeJ were used for exome
sequencing using a pre-mar k e tp r o d u c tf r o mA g i l e n t
(Agilent SureSelect
XT mouse all exon kit for exome
sequence capture). This uses 55,000 biotinylated
cRNAs to identify the exome and surrounding intronic
and intergenic information, including microRNAs.
Magnetic beads are then used to pull-down the rele-
vant DNA. Remaining DNA is washed away and the
cRNA digested.
DNA (2 to 3 μg in TE) was sheared to 100 to 400 bp
using a Covaris E210 (Covaris, Woburn, MA, USA).
Sheared DNA was subjected to Illumina paired-end
DNA library preparation according to manufacturer’s
recommendations (NEBNext DNA Sample Prep Set 1;
New England BioLabs, Ipswich, MA, USA) and the
adapter-ligated libraries were amplified for five to six
cycles using Herculase II (Agilent Technologies) with
PE1.0 and PE2.0 oligonucleotides (Illumina, San Diego,
CA, USA). Amplified library (500 ng) was hybridized to
the mouse bait library (SureSelect
XT Mouse All Exon
Kit; Agilent Technologies, catalogue number G7500A)
according to the manufacturer’s recommendations.
Hybridized material was captured using streptavidin-
coated beads (Invitrogen, Paisley, UK) and amplified for
10 to 11 cycles using Herculase II with PE1.0 and PE2.0
oligonucleotides (Illumina). Captured libraries were
sequenced on the Illumina Genome Analyzer II platform
as paired-end 76-bp reads according to the manufac-
turer’s protocol. Two lanes of sequence were generated
for each mouse.
Sequence data have been deposited in the European
Nucleotide Archive (accession number ERP000744).
Primers to amplify the regions containing the potential
DNA changes detected by Illumina sequencing were
designed using Primer 3 [85] and ordered from Sigma,
(Haverhill, Suffolk, UK) (Table 6). DNA from the origi-
nal sequenced mice underwent capillary sequencing to
exclude false positives. The same Isl1 primer and capil-
lary sequencing were used to assess mice from the rest
of the dearisch colony and other C3HeB/FeJ mice.
Indels and SNVs originally excluded by the final filtering
step before capillary sequencing were examined along
t h ee n t i r el e n g t ho fc h r o m o s o m e1 3t oe x c l u d ea n y
potentially pathogenic mutation that may be linked to
Isl1. The following wild-type mouse strains were also
sequenced to establish the Isl1 sequence: NOR/Lt, BUB/
BnJ, I/LnJ, C3HeB/FeJ, FVB/N, 129P2/OlaHsd, CBA,
PL/J, 101/H, C57BL/6J, SWR/J, P/J, BALB/c, LG/J,
CHMU/LeJ, MA/MyJ, SB/Le, PN/nBSwUmabJ, DBA/1J,
DA/HuSn, and SM/J.
Table 6 Primers used for capillary sequencing of the 23 SNVs and for genotyping the Isl1 mutation
Gene name Location Forward primer Reverse primer
1700001K19Rik 12:111907080 CTTCTTCTTCCTCTTAATTCTCTCAGG TTTAGATCCTTATGATGGTGACTCG
1700104B16Rik 8:34841236 TGTAGCAGACTGGGCTTTGC CTCCCTCAGTCCCTACAAGC
Acsl3 1:78692680 CTCTCACCTGTGTGCTCTGG CCTGATCTGCTAATGTCTGTGG
Bcl2l14 6:134377474 CTTCATCCTAAACAACCAGAAGTCC AGTGTGATTAGAGCTAGTCCTCTTCTCC
Btnl7 17:34670007 AGAGAGTTCCTGGCATGTGG CAGGCTTAGGACTGGAGACG
Catsper2 2:121223476 CTGGATGTCTTACACTCACTACACTGC CTATATGTACAGAGGGACCAGTCTTGG
Col6a3 1:92672331 CAGGCATAAAAGATGGTGTCTCTAAG GACCAAACCAACAGCAATTGTAAAC
Creb3l2 6:37284584 GATGCCCTGAGCAGAGAGG TGCAGAAAGCCAAACCTAGC
Gm10859 2:5833494 AATCTCAGTTGAGAGAAAACCTACG GAGATAGCTCAGTCAGTCAGTCAGG
Gm11149 9:49380322 GACATTCTCTAAAAGCAGAGACATCC ACGGACTACAGTCTAAAACATCTAAGC
Gtf3c2 5:31476808 CCTCAAATCCAGGCAAAGG CTCGTTGCTGTATCTCTGTGC
H2-Oa 17:34229420 CTAACCTGGACTCTGTTTCTTTTTACC CTACATTTCCACTGACTCTTTCAGAGC
Ido1 8:25703857 CCGGTAGTGGATGCTGTAGG CTCTAAGTGACCTCCGTGAGC
Isl1 13:117098488 CACTGGGCACTCTAAAGTAAACG TTCTCCGGATTTGGAGTGG
Mdc1 17:35984844 CATCTGCAGGACTGCCTAGC TGGGACTTGACCTCTTCTGC
Olfr424 1:176066876 GGACAAAGAATAACACAGATTTTCC GAACAAAGGAATGAAGAAGAGG
Olfr573-ps1 7:110091057-8 AGAGGAAGTAGTACATAGGCTCATGG CTACTGAAAGAGTTAACTTAGTGGAGAGG
Olfr749 14:51356853 AGACAGAATGTTGGCTAGTATGTTAGG CTAATTATCTAGATCGCCTTTGACTCC
Rsf1 7:104809403-4 GACACTAAAAGTAGAAAGCAGTCACC GCTTTTCTAGCTTTACAATGACTGG
Sap30bp 11:115825338 CAACACAGGAAATGGACACG AACCAACAGGACCCAGAGG
U1 1:172958261 TAAATACTTACCTGGCAGGAGAGATACC TTATATTGGTGCACTAGCTTCATGC
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Page 16 of 19Three-dimensional modeling
We used the PDBsum database [86] to find all structural
models containing one or more LIM domains (Pfam
identifier PF00412), and then examined those having
two tandem LIM domains to find any that might be in
complex with a binding partner. One such was PDB
entry 2xjy, solved by X-ray crystallography to 2.4 Å
resolution. This is a complex of human rhombotin-2
(aka LMO2) and a 35-residue fragment of a LIM-inter-
a c t i o nd o m a i n( L I D )f r o mh u m a nL I Md o m a i n - b i n d i n g
protein 1.
We used the SWISS-MODEL server [87] to build
automatically a three-dimensional homology model of
ISL1 using the three-dimensional structure of rhombo-
tin-2 from PDB entry 2xjy as our template. The
sequence identity of the two LIM domains in the two
proteins is 34% over 126 residues, giving an E-value of 9
×1 0
-32, so the model is expected to be a good approxi-
mation of the structure of Isl1. To our model we added
the LID fragment from PDB entry 2xjy (by cut-and-
paste between PDB files), and noted that the Tyr84-
Asp354 side chain interaction from 2xjy was retained as
Tyr81-Asp354 in our model.
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